Abstract
The imprinted expression of the IGF2 and H19 genes is controlled by the imprinting control region 1 (ICR1) located at chromosome 11p15.5. DNA methylation defects involving ICR1 result in two growth disorders with opposite phenotypes: an overgrowth disorder, the Beckwith–Wiedemann syndrome (maternal ICR1 hypermethylation in 10% of BWS cases) and a growth retardation disorder, the Silver–Russell syndrome (paternal ICR1 loss of methylation in 60% of SRS cases). In familial BWS, hypermethylation of ICR1 has been found in association with microdeletion of repetitive DNA motifs within ICR1 that bind the zinc finger protein CTCF; but more recently, ICR1 point mutations were described in BWS pedigrees. We present a case report of two brothers with BWS and prolonged post-pubertal growth resulting in very large stature. A maternally inherited point mutation was identified in ICR1 in both brothers, which altered binding of OCT transcription factors. The same mutation was present on the paternally inherited allele of their unaffected mother. This is a second report of a point mutation causing ICR1 hypermethylation by altering an OCT-binding motif. The atypical growth phenotype of the brothers may be connected to the unusual underlying cause of their BWS.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Weksberg R, Shuman C, Beckwith JB : Beckwith-Wiedemann syndrome. Eur J Hum Genet 2009; 18: 8–14.
Ideraabdullah FY, Vigneau S, Bartolomei MS : Genomic imprinting mechanisms in mammals. Mut Res 2008; 647: 77–85.
Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A : Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 2004; 36: 958–960.
Prawitt D, Enklaar T, Gartner-Rupprecht B et al: Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci USA 2005; 102: 4085–4090.
Cerrato F, Sparago A, Verde G et al: Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 2008; 17: 1427–1435.
Demars J, Shmela ME, Rossignol S et al: Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet 2010; 19: 803–814.
Mackay DJG, Callaway JLA, Marks SM et al: Hypomethylation of multiple imprinted loci in patients with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 2008; 40: 949–951.
Poole RL, Baple E, Crolla JA, Temple IK, Mackay DJG : Investigation of a routine cohort referred for molecular cytogenetic analysis using aCGH reveals previously unsuspected anomalies of imprinting. Am J Med Genet 2010; 152A: 1990–1993.
Scott RH, Douglas J, Baskcomb L et al: Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms' tumor. Nat Genet 2008; 40: 1329–1334.
Hori N, Nakano H, Takeuchi T et al: A dyad oct-binding sequence functions as a maintenance sequence for the unmethylated state within the H19/Igf2-imprinted control region. J Biol Chem 2002; 277: 27960–27967.
Shuman C, Beckwith JB, Smith AC, Weksberg R : Beckwith-Wiedemann syndrome; in Pagon RA, Bird TC, Dolan CR et al, (eds): GeneReviews [Internet]. Seattle: University of Washington, 1993 (http://www.ncbi.nlm.nih.gov/sites/GeneTests/review?db=GeneTests).
Acknowledgements
This study was funded by the Newlife Foundation for Disabled Children.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Poole, R., Leith, D., Docherty, L. et al. Beckwith–Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2/H19-imprinting control region, ICR1. Eur J Hum Genet 20, 240–243 (2012). https://doi.org/10.1038/ejhg.2011.166
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2011.166
Keywords
This article is cited by
-
Components of IGF-axis in growth disorders: a systematic review and patent landscape report
Endocrine (2022)
-
The extent of DNA methylation anticipation due to a genetic defect in ICR1 in Beckwith-Wiedemann syndrome
Journal of Human Genetics (2019)
-
Overgrowth syndromes — clinical and molecular aspects and tumour risk
Nature Reviews Endocrinology (2019)
-
Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
Clinical Epigenetics (2018)
-
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
Nature Reviews Endocrinology (2018)
